IDEXX Laboratories Financials
| IX1 Stock | EUR 406.20 6.80 1.70% |
IDEXX |
Understanding current and past IDEXX Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of IDEXX Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in IDEXX Laboratories' assets may result in an increase in income on the income statement.
IDEXX Laboratories Stock Summary
IDEXX Laboratories competes with Danaher, Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, and Talanx AG. IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US45168D1046 |
| Business Address | One IDEXX Drive, |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.idexx.com |
| Phone | 207 556 0300 |
| Currency | EUR - Euro |
You should never invest in IDEXX Laboratories without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of IDEXX Stock, because this is throwing your money away. Analyzing the key information contained in IDEXX Laboratories' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
IDEXX Laboratories Key Financial Ratios
There are many critical financial ratios that IDEXX Laboratories' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that IDEXX Laboratories reports annually and quarterly.| Return On Equity | 1.05 | |||
| Return On Asset | 0.22 | |||
| Target Price | 707.0 | |||
| Beta | 1.17 | |||
| Z Score | 32.8 |
IDEXX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IDEXX Laboratories's current stock value. Our valuation model uses many indicators to compare IDEXX Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IDEXX Laboratories competition to find correlations between indicators driving IDEXX Laboratories's intrinsic value. More Info.IDEXX Laboratories is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IDEXX Laboratories is roughly 4.83 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IDEXX Laboratories' earnings, one of the primary drivers of an investment's value.IDEXX Laboratories Systematic Risk
IDEXX Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IDEXX Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on IDEXX Laboratories correlated with the market. If Beta is less than 0 IDEXX Laboratories generally moves in the opposite direction as compared to the market. If IDEXX Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one IDEXX Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IDEXX Laboratories is generally in the same direction as the market. If Beta > 1 IDEXX Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
IDEXX Laboratories November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of IDEXX Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of IDEXX Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of IDEXX Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing IDEXX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IDEXX Laboratories's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 10.09 | |||
| Value At Risk | (2.35) | |||
| Potential Upside | 1.88 |
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |